On the same line, IL6 can promote tumor cell expansion and, accordingly, elevated levels of this cytokine were reported to correlate with an increased risk of cancer progression in NSCLC patients [36,37]. This evidence concerns the gene IL6 and non-small cell lung carcinoma.